Showing 1671-1680 of 5771 results for "".
- AbbVie and iSTAR Medical Announce Strategic Alliancehttps://modernod.com/news/abbvie-and-istar-medical-announce-strategic-alliance/2480980/AbbVie and iSTAR Medical announced a strategic transaction to further develop and commercialize iSTAR Medical’s MINIject device, a minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma. The deal gives AbbVie the exclusive right to acquire iST
- Apellis Announces FDA Acceptance and Priority Review of the NDA for Pegcetacoplan for the Treatment of Geographic Atrophyhttps://modernod.com/news/apellis-announces-fda-acceptance-and-priority-review-of-the-nda-for-pegcetacoplan-for-the-treatment-of-geographic-atrophy/2480973/Apellis Pharmaceuticals announced that the FDA has accepted and granted Priority Review designation for the intravitreal pegcetacoplan new drug application (NDA). Pegcetacoplan is an investigational, targeted C3 therapy for the treatment of geographic atrophy (GA) secondary to age-relat
- Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operationshttps://modernod.com/news/eyenovia-provides-manufacturing-update-and-announces-appointment-of-bren-kern-as-svp-of-manufacturing-and-operations/2480971/Eyenovia provided an update on its expanded manufacturing capabilities and also announced the appointment of Bren Kern as Senior Vice President of Manufacturing and Operations. The company announced that its new manufacturing facility in Redwood City, Cal
- Prevent Blindness Holds 11th Annual Focus on Eye Health National Summit as Two-Day Virtual Eventhttps://modernod.com/news/prevent-blindness-holds-11th-annual-focus-on-eye-health-national-summit-as-two-day-virtual-event/2480966/Preventg Blindness held the 11th annual Prevent Blindness Focus on Eye Health National Summit as a virtual event on July 13-14, 2022. This year’s Summit engaged more than 840 registered attendees, and included a variety of presentations related to the theme "Eye-conic Ap
- Euclid Vision Announces Official Launch of Cloud-Based Portalhttps://modernod.com/news/euclid-vision-announces-official-launch-of-cloud-based-portal/2480964/Euclid Vision has announced the official rollout of MyEuclid, an interactive, web-based customer portal designed to drive practice efficiency and optimize Euclid Ortho-K fits. The MyEuclid portal was released on a limited basis earlier this year, and the platform is now availa
- Xequel Bio Announces Positive Results from Phase 1b Study of iNexin, a Novel aCT1 Ophthalmic Solutionhttps://modernod.com/news/xequel-bio-announces-positive-results-from-phase-1b-study-of-inexin-a-novel-act1-ophthalmic-solution/2480963/Xequel Bio announced positive results from its phase 1b clinical trial with iNexin (aCT1 ophthalmic solution) for the treatment of corneal injury in patients with dry eye disease. The study demonstrated that iNexin was safe and well-tolerated at the doses tested, and ear
- Bausch + Lomb Announces Efficiency-Enhancing Upgrades for Stellaris Elite Vision Enhancement Systemhttps://modernod.com/news/bausch-lomb-announces-efficiency-enhancing-upgrades-for-stellaris-elite-vision-enhancement-system/2480960/Bausch + Lomb announced the first in a series of upgrades for the Stellaris Elite vision enhancement system designed to enhance efficiency. The upgrades include an increase to the maximum vacuum setting from 600 to 660 mmHg and an enhancement to the removable valve caps in the troc
- Samsara Vision Announces First US Surgeries of the SING IMT for AMD as Part of the CONCERTO Studyhttps://modernod.com/news/samsara-vision-announces-first-us-surgeries-of-the-sing-imt-for-aamd-as-part-of-the-concerto-study/2480955/Samsara Vision announced the completion of the first US surgeries of its SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope), as part of the CONCERTO clinical study, a US-based FDA study to evaluate improvements in visual acuity and safety of the device
- Nicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular Hemodynamics and Retinal Cell Physiologyhttps://modernod.com/news/nicox-announces-publication-of-ncx-470-results-demonstrating-improvements-to-ocular-hemodynamics-and-retinal-cell-physiology-1/2480951/Nicox SA announced that the results from studies on the beneficial effects of NCX 470 in a nonclinical model of endothelin-1 (ET-1)-induced ischemia/reperfusion damage of the optic nerve head and retina have been published online in the peer-reviewed Journal of Ocular Pharmacology and Therape
- Ocuphire Announces Late-Breaking Paper for Nyxol for Reversal of Dilation Indication at Annual ASRS Meetinghttps://modernod.com/news/ocuphire-announces-late-breaking-paper-for-nyxol-for-reversal-of-dilation-indication-at-annual-asrs-meeting/2480950/Ocuphire Pharma today announced six presentations in July at meetings of the American-European Congress of Ophthalmic Surgery (AECOS), American Society of Retina Specialists (ASRS), Ophthalmology Innovation Summit (OIS), and the Octane and National Medical Association (NMA). At ASR